To 200,000 m/z and Beyond: Native Electron Capture Charge Reduction Mass Spectrometry Deconvolves Heterogeneous Signals in Large Biopharmaceutical Analytes

  • Kyle I.P. Le Huray
  • , Tobias P. Wörner
  • , Tiago Moreira
  • , Marcin Dembek
  • , Maria Reinhardt-Szyba
  • , Paul W.A. Devine
  • , Nicholas J. Bond
  • , Kyle L. Fort*
  • , Alexander A. Makarov*
  • , Frank Sobott*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Great progress has been made in the detection of large biomolecular analytes by native mass spectrometry; however, characterizing highly heterogeneous samples remains challenging due to the presence of many overlapping signals from complex ion distributions. Electron-capture charge reduction (ECCR), in which a protein cation captures free electrons without apparent dissociation, can separate overlapping signals by shifting the ions to lower charge states. The concomitant shift to higher m/z also facilitates the exploration of instrument upper m/z limits if large complexes are used. Here we perform native ECCR on the bacterial chaperonin GroEL and megadalton scale adeno-associated virus (AAV) capsid assemblies on a Q Exactive UHMR mass spectrometer. Charge reduction of AAV8 capsids by up to 90% pushes signals well above 100,000 m/z and enables charge state resolution and mean mass determination of these highly heterogeneous samples, even for capsids loaded with genetic cargo. With minor instrument modifications, the UHMR instrument can detect charge-reduced ion signals beyond 200,000 m/z. This work demonstrates the utility of ECCR for deconvolving heterogeneous signals in native mass spectrometry and presents the highest m/z signals ever recorded on an Orbitrap instrument, opening up the use of Orbitrap native mass spectrometry for heavier analytes than ever before.

Original languageEnglish
Pages (from-to)1548-1561
Number of pages14
JournalACS Central Science
Volume10
Issue number8
DOIs
Publication statusPublished - 28 Aug 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors. Published by American Chemical Society.

Funding

K.I.P.L.H. is funded by Biotechnology and Biological Sciences Research Council grant BB/M011151/1 and T.M. by Biotechnology and Biological Sciences Research Council grant BB/W510397/1. We acknowledge the use of the Biomolecular Mass Spectrometry Facility (University of Leeds), the assistance of Dr. James Ault, and Wellcome Trust funding (208385/Z/17/Z) to Prof. Frank Sobott for the UHMR instrument. The authors thank Dr. Ralf Hartmann, Dr. Dmitry Strelnikov, Dr. Konstantin Aizikov, Dr. Eduard Denisov, Dr. Denis Chernyshev, and Dr. Frederik Busse (Thermo Fisher Scientific), Prof. Vicki Wysocki (Ohio State University), and Prof. Joe Beckman (Oregon State University) for helpful discussions during this work.

FundersFunder number
Biotechnology and Biological Sciences Research CouncilBB/M011151/1, BB/W510397/1
Wellcome Trust208385/Z/17/Z
Wellcome Trust208385/Z/17/Z

    Fingerprint

    Dive into the research topics of 'To 200,000 m/z and Beyond: Native Electron Capture Charge Reduction Mass Spectrometry Deconvolves Heterogeneous Signals in Large Biopharmaceutical Analytes'. Together they form a unique fingerprint.

    Cite this